Fatal pneumonitis associated with postoperative intensity-modulated radiotherapy in lung cancer: Case report and review

Oncology Letters

Volumn 5, Issue 2, 2013, Pages 714-716

  Hu, Yan ^a   Li, Jingjing ^a   Su, Xiaoyan ^a  

^a Department of Oncology   (China)

Author keywords

Intensity modulated radiotherapy; Low dose irradiated volume; Radiation pneumonitis

Indexed keywords

ANTIBIOTIC AGENT; CISPLATIN; METHYLPREDNISOLONE; NAVELBINE;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DYSPNEA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG CANCER; MALE; RADIATION DOSE; RADIATION PNEUMONIA;

EID: 84871562817     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.1053     Document Type: Article

References (14)

1. Kataria T, Rawat S, Sinha SN, Garg C, Bhalla NK and Negi PS: Dose reduction to normal tissues as compared to the gross tumor by using intensity modulated radiotherapy in thoracic malignancies. Radiat Oncol 1: 31, 2006.
2. Jiang ZQ, Yang K, Komaki R, Wei X, Tucker SL, ZhuangY, Martel MK, Vedam S, Balter P, Zhu G, Gomez D, et al: Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small-cell lung cancer: the MD Anderson experience. Int J Radiat Oncol Biol Phys 11: 1-8, 2011.
3. Tsujino K, Hirota S, Endo M, Obayashi K, Kotani Y, SatouchiM, Kado T and Takada Y: Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys55: 110-115, 2003.
4. Kong FM, Ritter T, Quint DJ, Senan S, Gaspar LE, Komaki RU, Hurkmans CW, Timmerman R, Bezjak A, Bradley JD, Movsas B, et al: Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Int J Radiat Oncol Biol Phys 81: 1442-1457, 2011.
5. Belderbos JS, Heemsbergen WD, De Jaeger K, Baas P and Lebesque JV: Final results of a Phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66: 126-134, 2006.
6. Murshed H, Liu HH, Liao Z, Barker JL, Wang X, Tucker SL, Chandra A, Guerrero T, Stevens C, Chang JY, Jeter M, et al: Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int JRadiat Oncol Biol Phys 58: 1258-1267, 2004.
7. Yorke ED, Jackson A, Rosenzweig KE, Braban L, Leibel SA and Ling CC: Correlation of dosimetrie factors and radiation pneumonitis for non-small cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys63: 672-682, 2005.
8. Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu CS, MohanR, Cox JD and Komaki R: Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 66: 1399-1407, 2006.
9. Dai H, Hui Z, Ji W, Liang J, Lu J, Ou G, Zhou Z, Feng Q, XiaoZ, Chen D, Zhang H, et al: Postoperative radiotherapy for resected pathological stage IIIA-N2 non-small cell lung cancer: a retrospective study of 221 cases from a single institution. Oncologist16: 641-650, 2011.
10. Ji W, Wang LH, Ou GF, Hang J, Feng QF, Chen DF, Zhou ZM, Zhang HX, Xiao ZF and Yin WB: Risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with postoperative three-dimensional conformal radiotherapy. Chin J Radiat Oncol18: 274-277, 2009.
11. Jang SY, Liu HH and Mohan R: Underestimation of low-dose radiation in treatment planning of intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 71: 1537-1546, 2008.
12. Shi A, Zhu G, Wu H, Yu R, Li F and Xu B: Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy. Radiat Oncol 5: 35, 2010.
13. Vogelius IS, Westerly DC, Cannon GM, Mackie TR, MehtaMP, Sugie C and Bentzen SM: Intensity-modulated radiotherapy might increase pneumonitis risk relative to three-dimensional conformal radiotherapy in patients receiving combined chemotherapy and radiotherapy: a modeling study of dose dumping. IntJ Radiat Oncol Biol Phys 80: 893-899, 2011.
14. Dang J, Li G, Lu X, Yao L, Zhang S and Yu Z: Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. J Cancer Res Clin Oncol136: 1169-1178, 2010.